← Back to Search

Robot-Assisted Therapy for Stroke

N/A
Recruiting
Led By Michelle J Johnson, PhD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Stroke diagnosis
Upper arm manual muscle strength scores >1
Must not have
Severe cognitive function
No cerebellum lesions due to stroke
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after 12 sessions (post-pre), after follow-up at 4 weeks (post-follow-up)

Summary

This trial is testing a new rehabilitation method for stroke patients using simple robots that help with exercises. The robots provide feedback and can be used alone or in groups to play therapy games. The goal is to see if this method is as effective as traditional therapy and if it can make quality care more accessible in community settings. Robots were introduced in rehabilitation in the 90s to reduce the physical effort of therapists.

Who is the study for?
This trial is for stroke survivors aged 55 or older, who are more than 3 months post-stroke with hemiplegia. Participants must be able to understand and speak, have mild to moderate arm muscle strength and motor control, and pain levels below severe on the NIH scale. Those with cerebellum lesions from their stroke or severe cognitive issues cannot join.
What is being tested?
The study compares standard care against a combination of standard care plus robot-assisted therapy using the Rehab CARES system. This phase 2 trial involves community-based patients performing clinical assessments before and after each treatment approach.
What are the potential side effects?
While specific side effects aren't detailed here, robot-assisted therapy may include discomfort or fatigue during exercises, skin irritation from equipment use, and potential frustration if progress is slower than expected.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a stroke.
Select...
I can move my arms against gravity.
Select...
I have weakness on one side of my body due to a stroke.
Select...
My arm and hand movement is limited but not completely lost.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have severe problems with my memory or thinking.
Select...
I have no brain damage from a stroke.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after 12 sessions (post-pre), after follow-up at 4 weeks (post-follow-up)
This trial's timeline: 3 weeks for screening, Varies for treatment, and after 12 sessions (post-pre), after follow-up at 4 weeks (post-follow-up) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Hand
Hand
Change in Motor Control
+4 more
Secondary study objectives
Range of Motion, Articular
Change in Cognition
Executive Function
+9 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Robot-Assisted Therapy with Rehab CARES systemExperimental Treatment1 Intervention
60 min sessions; 3 sessions per week; for 4 weeks;----of Upper Limb therapy using 1 or more affordable robots. Robot sessions can be group play and/or single play. Robot Assessment (B1-pre, B2-post, B3-follow-up#1, B4-follow-up#2)
Group II: Standard of CarePlacebo Group1 Intervention
60 min OT sessions; 3 sessions per week; for 4 weeks;-- augmented Standard therapy - consisting of PT, OT and SLP. Clinical Assessment (B1-pre, B2-post, B3-follow-up#1, B4-follow-up#2).

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for stroke, particularly in motor rehabilitation, include physical therapy, occupational therapy, and advanced methods like robot-assisted therapy. These treatments aim to enhance neuroplasticity, the brain's ability to reorganize and form new neural connections. Physical and occupational therapies involve repetitive, task-specific exercises that help retrain the brain and improve motor function. Robot-assisted therapy, such as the Rehab CARES system with force-feedback robots, provides precise, consistent, and intensive training. This technology aids in motor recovery by offering real-time feedback and adaptive resistance, which can accelerate the rehabilitation process. These mechanisms are crucial for stroke patients as they directly contribute to regaining independence and improving quality of life.

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,082 Previous Clinical Trials
42,727,261 Total Patients Enrolled
31 Trials studying Stroke
4,727 Patients Enrolled for Stroke
enAble Games LLCUNKNOWN
Recupero Robotics LLCUNKNOWN

Media Library

Robot-Assisted Therapy with Rehab CARES system Clinical Trial Eligibility Overview. Trial Name: NCT05542121 — N/A
Stroke Research Study Groups: Standard of Care, Robot-Assisted Therapy with Rehab CARES system
Stroke Clinical Trial 2023: Robot-Assisted Therapy with Rehab CARES system Highlights & Side Effects. Trial Name: NCT05542121 — N/A
Robot-Assisted Therapy with Rehab CARES system 2023 Treatment Timeline for Medical Study. Trial Name: NCT05542121 — N/A
~5 spots leftby May 2025